|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Additional conditions recognized in this trial | ||||
| Polyradiculoneuropathy | |||||
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | |||||
| 2 | More general conditions related to this trial | ||||
| Autoimmune Diseases | |||||
| Autoimmune Diseases of the Nervous System | |||||
| Demyelinating Diseases | |||||
| Immune System Diseases | |||||
| Nervous System Diseases | |||||
| Neuromuscular Diseases | |||||
| Peripheral Nervous System Diseases | |||||
| Polyneuropathies | |||||
| 3 | Interventions listed in this trial | ||||
| intravenous gammaglobulin | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Gamma-Globulins | |||||
| Immunoglobulins, Intravenous | |||||
| 5 | More general drug interventions related to this trial | ||||
| Immunologic Factors | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| 6 | Sponsors listed in this trial | ||||
| University of Aarhus | |||||